Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Cardea Bio and Nanosens Innovations Merge; Salk Scientist Receives NCI Award; Sorrento Therapeutics Closes $25M Registered Direct Offering

  • 2019-10-10T23:51:00.000+0000
  • California
  • Author: Lauren Panetta

10/10/19 – OncoSec
OncoSec Announces $30 Million USD Strategic Investment at a Premium to Market by China Grand Pharmaceutical and Healthcare Holdings (CGP) in Connection with Exclusive License to TAVO™ in Greater China and 35 Other Asian Countries

10/10/19 – Principia
Principia Announces Positive Preliminary Data of PRN1008 from its Ongoing Phase 2 Part B Trial in Pemphigus

10/10/19 – Inscopix
Inscopix to Leverage its Brain Mapping Platform to Pursue Novel Therapeutic Targets in Parkinson’s Disease

10/9/19 – Cardea Bio
Cardea Bio and Nanosens Innovations Inc. Merger-Acquisition Finalized

10/9/19 – FierceBiotech
Novo taps bluebird bio for gene-editing tech

10/9/19 – Salk
Salk scientist Tony Hunter receives National Cancer Institute Outstanding Investigator Award

10/9/19 – Sorrento Therapeutics
Sorrento Therapeutics Announces Closing of $25 Million Registered Direct Offering

10/9/19 – FierceBiotech
Bayer forms drug discovery pact with Japan's Riken Innovation

10/9/19 – Endpoints
Partner Bayer pushes Ionis' antithrombotic drug into mid-stage development

10/8/19 – GEN
Lonza, Prevail Therapeutics Partner on Gene Therapy Manufacturing

10/8/19 – Xconomy
LabFellows Looks to Become “Operating System” For Life Sciences Cos.

10/8/19 – FierceBiotech
GSK inks 5-year Lyell deal to take cell therapy to next level

10/8/19 – FierceBiotech
Qiagen to restructure around 15-year Illumina partnership

10/8/19 – FierceBiotech
Novartis' Xolair follow-up banishes hives in 42% of patients

10/8/19 – FierceBiotech
Merck taps 4D pharma for bacterial vaccine R&D project

10/7/19 – Economy
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M

10/4/19 – FierceBiotech
Astellas to support new LabCentral biomanufacturing incubator

10/4/19 – Xconomy
Precision IBD Rebrands as Prometheus and Strikes R&D Deal With Takeda

10/3/19 – FierceBiotech
Tenaya bags $92M to develop triple threat for heart disease

10/2/19 – GEN
Bayer, Arvinas Partner on PROTAC Joint Venture, Treatments for Cancer, CV, Gynecological Diseases

10/2/19 – Xconomy
Viscient Bio Proposes Organovo Merger to Tackle NASH and Go Beyond

10/1/19 – Xconomy
Molecular Assemblies Raises $12M to Advance Enzymatic DNA Synthesis

10/1/19 – GeekWire
Microsoft will use AI to supercharge Novartis’ giant drug-development engine

9/30/19 – Vertex
Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

9/29/19 – FierceBiotech
ESMO: Lilly's RET drug shrinks half of rare thyroid cancers